Iakovlev V N, Leonov A N
Biull Eksp Biol Med. 1983 May;95(5):48-50.
It has been demonstrated in experiments on 134 cats that during acute blood loss (24 +/- 0.8 ml/kg), hyperbaric oxygen therapy (3039 hPa, 60 min) stimulates cytochrome oxidase, eliminates compensatory activation of mitochondrial creatine kinase and maintains the hyperactivity of cytoplasmic creatine kinase in the diencephalon, stabilizes the elevated AMP content at the level of blood loss compensation stage, prevents the fall in pO2 and in the ATP level as well as that in the energy charge and creatine phosphate content in the sensomotor cortex and subcortex, that is typical for the decompensation stage. Besides, hyperbaric oxygen therapy also averts the development of the terminal state that supervenes in the majority of untreated animals.
在对134只猫进行的实验中已证明,在急性失血(24±0.8毫升/千克)期间,高压氧疗法(3039百帕,60分钟)可刺激细胞色素氧化酶,消除线粒体肌酸激酶的代偿性激活,并维持间脑中细胞质肌酸激酶的高活性,在失血代偿阶段稳定升高的AMP含量,防止pO2、ATP水平以及感觉运动皮层和皮层下能量电荷和磷酸肌酸含量下降,这是失代偿阶段的典型特征。此外,高压氧疗法还可避免大多数未治疗动物所出现的终末期状态的发展。